Antibiotic resistance is one of the most serious contemporary health challenges because it reduces the effectiveness of drugs used to treat bacterial infections and makes some diseases more difficult and costly to treat. Resistance occurs when bacteria acquire the ability to survive and multiply despite the presence of an antibiotic that was previously able to kill them or stop their growth. The human body does not become resistant to the antibiotic; rather, the bacteria themselves change due to genetic mutations or the acquisition of resistance genes from other bacteria. The misuse of antibiotics has accelerated this problem, such as taking them without a prescription, using them to treat viral infections, or stopping treatment before completing the prescribed course. Over-prescribing broad-spectrum antibiotics also leads to the elimination of susceptible bacteria, leaving resistant strains to multiply and spread. Bacteria employ multiple resistance mechanisms, including producing enzymes that deactivate the drug, altering the site where the antibiotic targets them, reducing the drug's penetration into the cell, and expelling it using specialized pumps. Resistance genes can also be transferred between bacteria via plasmids, allowing them to spread rapidly, even between different species. The causes of the problem are not limited to medical use; they also include the use of antibiotics in animal husbandry and agriculture, and their leakage into the environment and water. Resistant bacteria spread easily in hospitals due to the overuse of antibiotics, the presence of immunocompromised patients, medical equipment, and invasive procedures. Resistant infections can prolong illness and hospital stays, and increase the need for stronger, potentially more toxic or expensive drugs. A critical review of this problem reveals that developing new antibiotics alone is insufficient, as bacteria can develop resistance to new drugs over time. Relying solely on awareness campaigns is also limited in effectiveness without regulating antibiotic dispensing, monitoring prescriptions, and ensuring proper use. Reducing resistance requires diagnostic testing, culture, and sensitivity testing to identify the causative agent and select the most appropriate treatment, rather than relying on indiscriminate use. Antibiotic rationalization programs play a crucial role in selecting the appropriate drug, dosage, and duration, and in reviewing treatment based on laboratory results. Infection prevention through handwashing, sterilization, vaccination, and infection control within healthcare facilities is essential to reducing the need for antibiotics. Systems for monitoring resistant strains and exchanging data between laboratories, hospitals, and healthcare authorities must be developed. There is also a need to support scientific research to develop rapid diagnostic tools, vaccines, and alternative treatments, such as phages and antimicrobial agents. The concept of “One Health” is crucial in addressing this problem because it links human, animal, and environmental health. Doctors, pharmacists, patients, farmers, and government institutions share a responsibility to maintain the effectiveness of these medicines. Antibiotic resistance is not a future problem, but a present health reality that requires evidence-based decisions and local and international cooperation. Therefore, responsible antibiotic use, improved diagnosis, infection prevention, resistance monitoring, and support for innovation collectively represent the most effective way to reduce this threat and protect future generations.
Al-Mustaqbal University is ranked first among Iraqi private universities.